We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Atomic Force Microscopy Differentiates Cancerous from Normal Cells

By LabMedica International staff writers
Posted on 29 Apr 2009
Using an atomic force microscope, scientists discovered that cancer cells and normal cells had different cell surface properties. More...
The difference in the brush layers covering the cell surface might have a biological significance, and could be used for detection of cancer.

Brushes on the cell surface, mostly consisting of microridges and tiny hairs called microvilli, are important for interacting with the external environment. The investigators processed force measurements--taken from the cell surface using an atomic force microscope--according to a model that accounts for these brushes, to quantitatively show that cancerous cells are different. Normal cells have brushes of one length, whereas cancerous cells have mostly two brush lengths of significantly different densities.

The scientific group was led by Igor Sokolov, director of the Nanoengineering and Biotechnology Laboratories Center at Clarkson University (Potsdam, NY, USA). "Cancer cells are traditionally detected by biochemical means," said Professor Sokolov. "However, despite many years of success, those methods have not resulted in defeating cancer. Therefore, it is very important to search for alternative, nontraditional ways of looking at cancer. Investigation of the physical properties of cell surfaces might be one such nontraditional way."

The authors also demonstrated that the difference found in cell surface "brush" is practically impossible to find with other microscopic methods.

The study appeared online in Nature Nanotechnology, on April 13, 2009.

Related Links:

Clarkson University



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.